Physician

Peter Stevens Fail, MD

According to 2025 Medicare claims, Peter Fail, MD (NPI: 1437156429) practices advanced heart failure and transplant cardiology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Terrebonne, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (NPI: 1982689113; TIN: 720993441) and primary practice location at 70360-4413. Fail is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Fail's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,137 traditional Medicare patients, billed 48,655 HCPCS/CPT codes, and received $485,529 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,830 prescription claims across 1,567 beneficiaries totaling $3,739,148 in drug costs, led by Jardiance (Empagliflozin). DME data shows 35 claims. Open Payments data shows 179 records totaling $134,884. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $631,682 to $485,529. In contrast, Part D prescription costs have moved sharply higher in recent years, from $1,067,070 to $3,739,148. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $24,013 and ending at $11,857.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,089	45,391	$631,682
2016	1,882	45,541	$681,482
2017	1,831	44,770	$629,584
2018	1,601	44,673	$644,815
2019	1,400	35,235	$625,408
2020	1,261	37,982	$558,266
2021	1,112	29,025	$495,478
2022	960	22,222	$439,644
2023	981	27,437	$409,310
2024	1,137	48,655	$485,529

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,102	14,684	$1,067,070
2016	1,161	15,073	$1,630,123
2017	1,205	15,583	$1,041,167
2018	1,225	15,365	$1,064,198
2019	1,340	15,016	$1,169,485
2020	1,380	15,056	$1,269,501
2021	1,406	14,576	$1,407,466
2022	1,393	14,617	$2,029,965
2023	1,435	14,909	$2,969,877
2024	1,567	15,830	$3,739,148

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	119	$9,076
2016	22	166	$6,371
2017	35	154	$3,650
2018	24	321	$11,802
2019	N/R	178	$7,177
2020	N/R	64	$2,803
2021	N/R	50	$2,663
2022	N/R	29	$694
2023	N/R	62	$2,680
2024	N/R	35	$332

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	636	985	$83
80061	Blood test, lipids (cholesterol and triglycerides)	448	688	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	654	1,139	$12
84460	Liver enzyme (sgpt), level	380	600	$5
84075	Phosphatase (enzyme) level, alkaline	379	598	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	904	47,636	$918,872
Entresto	Sacubitril/Valsartan	674	36,712	$791,173
Vyndamax	Tafamidis	12	600	$452,686
Eliquis	Apixaban	423	22,497	$428,966
Camzyos	Mavacamten	30	900	$242,684

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	18	$167
A7037	Tubing used with positive airway pressure device	N	N/R	17	$164

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	141	$32,697	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	38	$102,187	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter Stevens Fail, MD?

Tedicare shows public-source Medicare data for Peter Stevens Fail, MD (NPI 1437156429), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter Stevens Fail, MD have ACO affiliation data?

Peter Stevens Fail, MD is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535).

What billing organization is linked to Peter Stevens Fail, MD?

Peter Stevens Fail, MD is linked to CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (billing NPI 1982689113) in the available physician profile data.

Does Peter Stevens Fail, MD have Open Payments data?

Peter Stevens Fail, MD has 179 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.